R

RELX

Global information analytics and decision tools

Product Marketing & Enablement Specialist

Full-TimeUpdated on 10/23/2026
$78.8k - $131.3k+ Annual incentive bonus
Mid
Horsham, PA, USA
HybridHybrid model includes in-office attendance on designated Level Up Days.
Growth & MarketingProduct Marketing
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • Experience in B2B product marketing, sales enablement, or related commercial marketing, ideally in Life Sciences regulatory or compliance-focused environments.
  • Strong knowledge of the Life Sciences industry, preferably with experience in pharmaceuticals, medical devices, regulatory affairs, regulatory technology or services, or a closely related market.
  • Excellent writing and editing skills, including the ability to translate technical ideas into clear, engaging copy.
  • Experience translating complex products, data, technology, or services into compelling value propositions and commercial messaging.
  • Demonstrated experience developing product positioning, go-to-market strategies, sales enablement tools, and customer-facing content.
  • Ability to make highly technical or regional concepts clear and relevant to different audiences through strong writing and editing.
  • Commercial mindset and understanding of how product marketing and enablement contribute to pipeline, revenue, adoption, and customer growth.
  • Comfort operating in a fast-paced, highly collaborative environment where priorities can shift.
  • Hands-on approach and ability to develop strategy and create the deliverables to execute it.
  • Experience using AI-enabled tools, or demonstrated ability and enthusiasm to adopt them to improve quality, insight, and speed.
  • Strong project management skills and ability to manage multiple projects simultaneously.
  • Ability to work within the hybrid Level Up model, including attending the office on designated Level Up Days for in-person collaboration with colleagues and cross-functional teams.
Responsibilities
  • Lead product marketing and go-to-market strategy for Life Sciences solutions, including positioning, messaging, and value proposition development.
  • Translate complex regulatory, data, and service offerings into clear, differentiated customer value and commercial narratives.
  • Develop customer personas, use cases, competitive positioning, and objection-handling frameworks.
  • Partner with Product, Regulatory Services, Sales, and subject matter experts to incorporate customer and market insights into product positioning.
  • Create and execute go-to-market plans for product launches, enhancements, and new capabilities.
  • Align product roadmap priorities with customer needs, market trends, and commercial opportunities.
  • Monitor competitive activity, regulatory developments, and market dynamics to provide actionable business recommendations.
  • Develop and maintain sales enablement resources, including pitch decks, product briefs, solution overviews, FAQs, and competitive materials.
  • Collaborate with Sales teams to identify and address messaging, training, and content gaps throughout the buyer journey.
  • Support sales readiness initiatives through training materials, launch communications, and product update resources.
  • Contribute to strategic account presentations, proposals, and high-value commercial opportunities.
  • Manage and optimize the Life Sciences Asset Platform in SharePoint to ensure easy access to current sales and marketing materials.
  • Create customer-facing content, including thought leadership, blogs, one-pagers, webinars, and campaign assets.
  • Partner with internal experts to develop differentiated perspectives on Life Sciences and regulatory topics.
  • Ensure consistency and accuracy of messaging across marketing campaigns, digital channels, and sales materials.
  • Support webinar and event marketing activities, including messaging development, speaker preparation, and follow-up content.
  • Identify and pursue speaking engagements and thought leadership opportunities, including proposal and abstract development.
  • Leverage approved AI tools to accelerate research, content creation, information synthesis, and workflow efficiency.
  • Drive adoption of AI and automation to improve the speed, quality, and scalability of product marketing and sales enablement efforts.
  • Apply sound judgment and quality controls to ensure accuracy, compliance, privacy, and regulatory adherence in all marketing and enablement activities.
Desired Qualifications
  • Strong knowledge of the Life Sciences industry with experience in pharmaceutical, medical device, regulatory affairs, regulatory technology/services, or a closely related market is strongly preferred.

About the company

RELX is a global provider of information-based analytics and decision tools for professionals across scientific, technical, medical, legal, risk, business, and exhibitions industries. It operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products combine large datasets, analytics, and decision-support tools to help researchers, healthcare professionals, lawyers, and business leaders make informed choices, improve productivity, and achieve better outcomes. Revenue mainly comes from subscriptions, with additional income from transactional sales and advertising. RELX differentiates itself through its deep data assets, specialized industry knowledge, and multi-segment offerings that span content, analytics, and decision-support services. The company pursues a goal of delivering trusted information and insights while supporting corporate responsibility and alignment with the UN SDGs through its products and partnerships.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1894

Get referred to RELX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue grew 7%; Legal grew 10%; Risk grew 8%.
  • February 24, 2026 Lexis+ with Protégé launched globally, expanding AI workflow adoption.
  • September 3, 2026 Doctrine closes, targeting one million European legal professionals.

What critics are saying

  • Anthropic and Thomson Reuters compressed legal AI pricing after February 2026 market shock.
  • Harvey and Legora court law schools in 2026, training future buyer cohorts elsewhere.
  • Exhibitions face Middle East event uncertainty through 2026, threatening margins and calendar-dependent cash flows.

What makes RELX unique

  • LexisNexis’ 200 billion-document corpus still beats generic legal AI models.
  • September 3, 2026 Doctrine acquisition deepens RELX’s European legal AI workflow moat.
  • H1 2026 subscriptions supplied 62% of revenue, stabilizing cash generation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Wellness Program
  • Mental Health Support
  • Family Planning Benefits
  • Health Savings Account/Flexible Spending Account
  • Flexible Work Hours

Company News

Yahoo Finance
Oct 23rd, 2026
RELX reports 7% underlying revenue growth as AI demand backs full-year outlook

RELX reported 7% underlying revenue growth for the first nine months of 2026, with its Legal, Risk, and STM divisions all contributing. Management reiterated its expectation of strong full year growth in revenue, adjusted operating profit, and constant currency adjusted earnings per share (EPS). AI-powered analytics tools, such as Lexis+ Protégé and LeapSpace, are becoming central to RELX's subscription model. The main risk is that competing or open source AI options could pressure its ability to charge a premium while it keeps investing heavily in new products. Analysts forecast revenue of £12.0bn and earnings of £2.9bn by 2029, implying 7.3% yearly revenue growth. Earnings are currently £2.3bn.

Yahoo Finance
Oct 22nd, 2026
RELX reaffirms 2026 outlook as nine-month underlying revenue grows 7%, led by Legal at 10%

RELX, the global provider of information-based analytics and decision tools, reported underlying revenue growth of 7% for the first nine months of 2026. It reaffirmed its full year outlook. Legal grew 10%, Risk 8%, and Scientific, Technical & Medical 6%. Exhibitions rose 4%, held back by disruption in the Middle East. Growth came from AI-enabled analytics and decision tools. RELX's research-grade AI workspace, LeapSpace, is seeing rapid usage growth. RELX expects another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share at constant currency.

Citybiz
Apr 28th, 2026
RELX to Acquire Legaltech Platform Doctrine in European AI Push

RELX Group has entered into an agreement to acquire French legal technology company Doctrine, a move that would expand its... Read More

Business Insider
Mar 1st, 2026
LexisNexis CEO dismisses AI threat as company reports 7% revenue growth

LexisNexis CEO Sean Fitzpatrick has dismissed investor concerns that AI threatens the legal software giant, saying proprietary data gives it a competitive advantage. Shares of parent company Relx fell 14% on 3 February following Anthropic's launch of an AI agent that drafts legal briefs, and are down 17% year-to-date. Fitzpatrick said LexisNexis's database of 200 billion legal documents, including content from Shepard's Citations dating to 1873, cannot be replicated by AI model makers. The company doesn't license its proprietary data to general-purpose AI providers. Relx reported 7% revenue growth for 2025 and 9% increase in adjusted operating profit, driven by customers adopting AI tools. LexisNexis is hiring and hasn't conducted AI-related redundancies.

Yahoo Finance
Feb 22nd, 2026
RELX's LexisNexis launches AI-powered identity management platform for healthcare

LexisNexis Risk Solutions, a wholly owned subsidiary of RELX, has launched a new identity management platform for the healthcare sector. Announced on 19 February, the tool combines identity verification, matching and enrichment capabilities with AI-powered authentication to enhance security throughout patients' healthcare journeys. The platform integrates LexisNexis IDVerse and offers enhanced identity verification, resolution and fraud protection. For healthcare professionals, it accelerates onboarding processes, automates processing and provides digital checks to prevent fraud. RELX is a global information and analytics company serving professional and business customers across scientific, technical, medical, legal and risk management markets.